Literature DB >> 2159091

Establishment of a karyotypically normal B-chronic lymphocytic leukemia cell line; evidence of leukemic origin by immunoglobulin gene rearrangement.

D Saltman1, N S Bansal, F M Ross, J A Ross, G Turner, K Guy.   

Abstract

A new Epstein-Barr virus (EBV) transformed cell line was established from a patient with B-chronic lymphocytic leukemia (B-CLL). The karyotype of the cell line has remained normal for over 12 months in culture; however, identical heavy and light chain immunoglobulin (Ig) gene rearrangements in the patient's blood and the cell line provided evidence that the EBV transformed cells were derived from the neoplastic clone.

Entities:  

Mesh：

Year:  1990        PMID： 2159091     DOI： 10.1016/0145-2126(90)90167-8

Source DB:  PubMed          Journal:  Leuk Res        ISSN： 0145-2126            Impact factor:   3.156


  9 in total

1.  CLL-cell-mediated MDSC induction by exosomal miR-155 transfer is disrupted by vitamin D.

Authors:  H Bruns; M Böttcher; M Qorraj; M Fabri; S Jitschin; J Dindorf; L Busch; R Jitschin; A Mackensen; D Mougiakakos
Journal:  Leukemia       Date:  2016-12-23       Impact factor: 11.528

2.  A human monoclonal antibody drug and target discovery platform for B-cell chronic lymphocytic leukemia based on allogeneic hematopoietic stem cell transplantation and phage display.

Authors:  Sivasubramanian Baskar; Jessica M Suschak; Ivan Samija; Ramaprasad Srinivasan; Richard W Childs; Steven Z Pavletic; Michael R Bishop; Christoph Rader
Journal:  Blood       Date:  2009-08-10       Impact factor: 22.113

3.  Detection of EBV, HBV, HCV, HIV-1, HTLV-I and -II, and SMRV in human and other primate cell lines.

Authors:  Cord C Uphoff; Sabine A Denkmann; Klaus G Steube; Hans G Drexler
Journal:  J Biomed Biotechnol       Date:  2010-04-29

4.  Concurrent epigenetic silencing of wnt/β-catenin pathway inhibitor genes in B cell chronic lymphocytic leukaemia.

Authors:  Evgeny A Moskalev; Katrin Luckert; Ivan A Vorobjev; Sergey E Mastitsky; Aleena A Gladkikh; Achim Stephan; Marita Schrenk; Kamil D Kaplanov; Olga B Kalashnikova; Oliver Pötz; Thomas O Joos; Jörg D Hoheisel
Journal:  BMC Cancer       Date:  2012-06-06       Impact factor: 4.430

5.  Correction of PCR-bias in quantitative DNA methylation studies by means of cubic polynomial regression.

Authors:  Evgeny A Moskalev; Mikhail G Zavgorodnij; Svetlana P Majorova; Ivan A Vorobjev; Pouria Jandaghi; Irina V Bure; Jörg D Hoheisel
Journal:  Nucleic Acids Res       Date:  2011-04-12       Impact factor: 16.971

6.  Identification of a STAT5 target gene, Dpf3, provides novel insights in chronic lymphocytic leukemia.

Authors:  Marina Theodorou; Matthaios Speletas; Antigoni Mamara; Georgia Papachristopoulou; Vassiliki Lazou; Andreas Scorilas; Eleni Katsantoni
Journal:  PLoS One       Date:  2013-10-14       Impact factor: 3.240

7.  miR-181b as a therapeutic agent for chronic lymphocytic leukemia in the Eµ-TCL1 mouse model.

Authors:  Antonella Bresin; Elisa Callegari; Lucilla D'Abundo; Caterina Cattani; Cristian Bassi; Barbara Zagatti; M Grazia Narducci; Elisabetta Caprini; Yuri Pekarsky; Carlo M Croce; Silvia Sabbioni; Giandomenico Russo; Massimo Negrini
Journal:  Oncotarget       Date:  2015-08-14

8.  Peptide-guided targeting of GPR55 for anti-cancer therapy.

Authors:  Maria Mangini; Enrico Iaccino; Maria Giovanna Mosca; Selena Mimmi; Rosa D'Angelo; Ileana Quinto; Giuseppe Scala; Stefania Mariggiò
Journal:  Oncotarget       Date:  2017-01-17

9.  Gene expression profile induced by arsenic trioxide in chronic lymphocytic leukemia cells reveals a central role for heme oxygenase-1 in apoptosis and regulation of matrix metalloproteinase-9.

Authors:  Irene Amigo-Jiménez; Elvira Bailón; Noemí Aguilera-Montilla; José A García-Marco; Angeles García-Pardo
Journal:  Oncotarget       Date:  2016-12-13
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.